Suchergebnisse - "Safra, Tamar"

PubPharm (20)

1

Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer : final results from Study 10

enthalten in: British journal of cancer | 2023

von Kristeleit, R. | Drew, Y. | Oza, A. | +13

2

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Monk, B. | Parkinson, C. | Lim, M. | +36

CommentIn: J Clin Oncol. 2023 Feb 1;41(4):935-936. - PMID 36201722

3

Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial

enthalten in: Gynecologic oncology | 2022

von Chase, D. | Marín, M. | Backes, F. | +18

4

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4) : an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Kristeleit, R. | Lisyanskaya, A. | Fedenko, A. | +22

CommentIn: Lancet Oncol. 2022 Apr;23(4):440-441. - PMID 35298905

5

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer : Results From the KEYNOTE-158 Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von O'Malley, D. | Bariani, G. | Cassier, P. | +11

6

ATHENA (GOG-3020/ENGOT-ov45) : a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA-MONO) and rucaparib in combination with nivolumab (ATHENA-COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Monk, B. | Coleman, R. | Fujiwara, K. | +18

7

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

enthalten in: The New England journal of medicine | 2021

von Colombo, N. | Dubot, C. | Lorusso, D. | +117

CommentIn: Nat Rev Clin Oncol. 2021 Dec;18(12):747. - PMID 34616034

8

Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Ciruelos, E. | Rugo, H. | Mayer, I. | +16

9

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

enthalten in: The New England journal of medicine | 2019

von González-Martín, A. | Pothuri, B. | Vergote, I. | +128

CommentIn: N Engl J Med. 2019 Dec 19;381(25):2471-2474. - PMID 31851805

10

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer

enthalten in: The New England journal of medicine | 2019

von André, F. | Ciruelos, E. | Rubovszky, G. | +118

CommentIn: Nat Rev Clin Oncol. 2019 Aug;16(8):466. - PMID 31127192